drugset / Trial / NCT02940002
BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
RandomizedParallel-groupDouble-blindOther
Summary
To explore the efficacy and safety of four BAY1003803 formulations by means of a within subject comparison in an open Psoriasis Plaque Test
Timeline
- Start
- 2016-10-12
- Primary completion
- 2017-01-27
- Completion
- 2017-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAY1003803 | Unknown | 0.01 % | Topical |
| Subject | BAY1003803 | Unknown | 0.1 % | Topical |
| Comparator | Betamethasone | Other / unclassified | 0.05 % | Topical |
| Comparator | Calcipotriol | Small molecule | 0.005 % | Topical |
| Comparator | clobetasol propionate | Small molecule | 0.05 % | Topical |